Eyecare Innovations Today: An Ophthalmic Educational Podcast Series en © 2022 Evolve Medical Education LLC. All Rights Reserved. In this podcast series, we’ll examine ocular disease through a different lens. A diverse group of ophthalmology and optometry experts will review the latest technologic innovations and help you implement the newest diagnostic and treatment strategies in ocular surface disease, presbyopia, glaucoma, complex corneas, and more! This podcast is a joint collaboration between Evolve Medical Education and The Fundingsland Group. https://megaphone.imgix.net/podcasts/f46e89e0-dd25-11ec-9a7f-efac093568f2/image/TFGEvolve_Podcast_Image_New_Size.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Eyecare Innovations Today: An Ophthalmic Educational Podcast Series no episodic Evolve Medical Education, LLC and The Fundingsland Group In this podcast series, we’ll examine ocular disease through a different lens. A diverse group of ophthalmology and optometry experts will review the latest technologic innovations and help you implement the newest diagnostic and treatment strategies in ocular surface disease, presbyopia, glaucoma, complex corneas, and more! This podcast is a joint collaboration between Evolve Medical Education and The Fundingsland Group. In this podcast series, we’ll examine ocular disease through a different lens. A diverse group of ophthalmology and optometry experts will review the latest technologic innovations and help you implement the newest diagnostic and treatment strategies in ocular surface disease, presbyopia, glaucoma, complex corneas, and more! This podcast is a joint collaboration between Evolve Medical Education and The Fundingsland Group.

]]> Evolve Medical Education, LLC stephanie@evolvemeded.com Navigating the Impact of Preservatives in Ophthalmic Medications: Insights From Dr. Robert J. Noecker https://evolvemeded.com/course/2339-interview-noecker?utm_source=megaphone&utm_medium=episode_description In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associated with ocular surface diseases. Dr. Noecker emphasizes the importance of exploring alternatives like preservative-free formulations or less toxic oxidizing preservatives, which should ensure effective glaucoma treatment without compromising ocular health. This activity is supported by an independent medical education grant from Théa Pharma. Fri, 07 Jun 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associated with ocular surface diseases. Dr. Noecker emphasizes the importance of exploring alternatives like preservative-free formulations or less toxic oxidizing preservatives, which should ensure effective glaucoma treatment without compromising ocular health. This activity is supported by an independent medical education grant from Théa Pharma. In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associated with ocular surface diseases. Dr. Noecker emphasizes the importance of exploring alternatives like preservative-free formulations or less toxic oxidizing preservatives, which should ensure effective glaucoma treatment without compromising ocular health.


This activity is supported by an independent medical education grant from Théa Pharma.

]]> 830 no Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care https://evolvemeded.com/course/2339-interview-kolko?utm_source=megaphone&utm_medium=episode_description In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisions a future where BAK-free alternatives take precedence in eye care, promoting better patient outcomes and adherence to treatment regimens. This activity is supported by an independent medical education grant from Théa Pharma. Thu, 06 Jun 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisions a future where BAK-free alternatives take precedence in eye care, promoting better patient outcomes and adherence to treatment regimens. This activity is supported by an independent medical education grant from Théa Pharma. In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisions a future where BAK-free alternatives take precedence in eye care, promoting better patient outcomes and adherence to treatment regimens.


This activity is supported by an independent medical education grant from Théa Pharma.

]]> 727 no Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe https://evolvemeded.com/course/2339-interview-radcliffe?utm_source=megaphone&utm_medium=episode_description In this episode, Nathan Radcliffe, MD, discusses the widespread use of benzalkonium chloride (BAK) in the US ophthalmic market. Dr. Radcliffe acknowledges concerns about its long-term effects, such as exacerbating dry eye and impacting the success of incisional glaucoma surgery. Preservative-free formulations are favored in Europe, and Dr. Radcliffe highlights the growing recognition among US eye care clinicians regarding the need for BAK alternatives. This activity is supported by an independent medical education grant from Théa Pharma. Wed, 05 Jun 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Nathan Radcliffe, MD, discusses the widespread use of benzalkonium chloride (BAK) in the US ophthalmic market. Dr. Radcliffe acknowledges concerns about its long-term effects, such as exacerbating dry eye and impacting the success of incisional glaucoma surgery. Preservative-free formulations are favored in Europe, and Dr. Radcliffe highlights the growing recognition among US eye care clinicians regarding the need for BAK alternatives. This activity is supported by an independent medical education grant from Théa Pharma. In this episode, Nathan Radcliffe, MD, discusses the widespread use of benzalkonium chloride (BAK) in the US ophthalmic market. Dr. Radcliffe acknowledges concerns about its long-term effects, such as exacerbating dry eye and impacting the success of incisional glaucoma surgery. Preservative-free formulations are favored in Europe, and Dr. Radcliffe highlights the growing recognition among US eye care clinicians regarding the need for BAK alternatives.


This activity is supported by an independent medical education grant from Théa Pharma.

]]> 684 no The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer https://evolvemeded.com/course/2339-interview-hommer?utm_source=megaphone&utm_medium=episode_description In this episode, Anton Hommer, MD, discusses the European perspective on adopting preservative-free pharmaceuticals, highlighting challenges like health care professionals’ reluctancy to change, diverse reimbursement systems, and higher costs. He compares single-use and multiuse drugs, considering factors such as environmental impact and cost-effectiveness. Dr. Hommer emphasizes the superior efficacy of preservative-free medications, especially in treating chronic conditions such as glaucoma, and anticipates an increase in their use to protect ocular health and enhance chronic disease management. This activity is supported by an independent medical education grant from Théa Pharma. Tue, 04 Jun 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Anton Hommer, MD, discusses the European perspective on adopting preservative-free pharmaceuticals, highlighting challenges like health care professionals’ reluctancy to change, diverse reimbursement systems, and higher costs. He compares single-use and multiuse drugs, considering factors such as environmental impact and cost-effectiveness. Dr. Hommer emphasizes the superior efficacy of preservative-free medications, especially in treating chronic conditions such as glaucoma, and anticipates an increase in their use to protect ocular health and enhance chronic disease management. This activity is supported by an independent medical education grant from Théa Pharma. In this episode, Anton Hommer, MD, discusses the European perspective on adopting preservative-free pharmaceuticals, highlighting challenges like health care professionals’ reluctancy to change, diverse reimbursement systems, and higher costs. He compares single-use and multiuse drugs, considering factors such as environmental impact and cost-effectiveness. Dr. Hommer emphasizes the superior efficacy of preservative-free medications, especially in treating chronic conditions such as glaucoma, and anticipates an increase in their use to protect ocular health and enhance chronic disease management.


This activity is supported by an independent medical education grant from Théa Pharma.

]]> 710 no Optics and Aberrations https://evolvemeded.com/course/2346-interview-6?utm_source=megaphone&utm_medium=episode_description Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the realm of optics and aberrations. They cover a range of topics, including spherical and chromatic aberrations, ABBE numbers, and residual refractive error. Additionally, they explore various intraocular lens (IOL) designs, emphasizing the impact of these designs and manufacturing processes on visual quality. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Fri, 15 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the realm of optics and aberrations. They cover a range of topics, including spherical and chromatic aberrations, ABBE numbers, and residual refractive error. Additionally, they explore various intraocular lens (IOL) designs, emphasizing the impact of these designs and manufacturing processes on visual quality. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the realm of optics and aberrations. They cover a range of topics, including spherical and chromatic aberrations, ABBE numbers, and residual refractive error. Additionally, they explore various intraocular lens (IOL) designs, emphasizing the impact of these designs and manufacturing processes on visual quality.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 882 no Lens Lights Filters https://evolvemeded.com/course/2346-interview-5?utm_source=megaphone&utm_medium=episode_description Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the potential benefits and drawbacks of incorporating light filters into lens designs, focusing specifically on blue and violet filters. As they explain the science behind these filters, Drs. Al-Mohtaseb and Koch discuss how they are revolutionizing our understanding of intraocular lenses (IOLs) and influencing the overall visual experience for patients, moving beyond theoretical considerations to practical implications. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Thu, 14 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the potential benefits and drawbacks of incorporating light filters into lens designs, focusing specifically on blue and violet filters. As they explain the science behind these filters, Drs. Al-Mohtaseb and Koch discuss how they are revolutionizing our understanding of intraocular lenses (IOLs) and influencing the overall visual experience for patients, moving beyond theoretical considerations to practical implications. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Zaina Al-Mohtaseb, MD, and Douglas D. Koch, MD, delve into the potential benefits and drawbacks of incorporating light filters into lens designs, focusing specifically on blue and violet filters. As they explain the science behind these filters, Drs. Al-Mohtaseb and Koch discuss how they are revolutionizing our understanding of intraocular lenses (IOLs) and influencing the overall visual experience for patients, moving beyond theoretical considerations to practical implications.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 524 no Reducing Posterior Capsule Opacification https://evolvemeded.com/course/2346-interview-4?utm_source=megaphone&utm_medium=episode_description Cathy McCabe, MD, and Karl Stonecipher, MD, discuss how factors such as lens design, material, and haptics influence the selection of intraocular lenses (IOLs) and affect patients’ long-term visual outcomes. They also delve into the management of posterior capsule opacification (PCO), emphasizing the importance of achieving patient satisfaction. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Wed, 13 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Cathy McCabe, MD, and Karl Stonecipher, MD, discuss how factors such as lens design, material, and haptics influence the selection of intraocular lenses (IOLs) and affect patients’ long-term visual outcomes. They also delve into the management of posterior capsule opacification (PCO), emphasizing the importance of achieving patient satisfaction. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Cathy McCabe, MD, and Karl Stonecipher, MD, discuss how factors such as lens design, material, and haptics influence the selection of intraocular lenses (IOLs) and affect patients’ long-term visual outcomes. They also delve into the management of posterior capsule opacification (PCO), emphasizing the importance of achieving patient satisfaction.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 854 no Innovations in Lens Technology and Visual Quality https://evolvemeded.com/course/2346-interview-3?utm_source=megaphone&utm_medium=episode_description Cathy McCabe, MD, and Karl Stonecipher, MD, delve into the intricacies of different lens designs, discussing how they impact both patient outcomes and surgeon experience. The conversation also explores the significance of patient education and emphasizes the value of making well-informed decisions based on factors such as corneal health and refractive history. Looking ahead, Drs. McCabe and Stonecipher shed light on forthcoming innovations while conveying their expectations for future developments in lens technologies. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Tue, 12 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Cathy McCabe, MD, and Karl Stonecipher, MD, delve into the intricacies of different lens designs, discussing how they impact both patient outcomes and surgeon experience. The conversation also explores the significance of patient education and emphasizes the value of making well-informed decisions based on factors such as corneal health and refractive history. Looking ahead, Drs. McCabe and Stonecipher shed light on forthcoming innovations while conveying their expectations for future developments in lens technologies. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Cathy McCabe, MD, and Karl Stonecipher, MD, delve into the intricacies of different lens designs, discussing how they impact both patient outcomes and surgeon experience. The conversation also explores the significance of patient education and emphasizes the value of making well-informed decisions based on factors such as corneal health and refractive history. Looking ahead, Drs. McCabe and Stonecipher shed light on forthcoming innovations while conveying their expectations for future developments in lens technologies.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 931 no Impact of Lens Materials on Optical Quality https://evolvemeded.com/course/2346-interview-2?utm_source=megaphone&utm_medium=episode_description Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, discuss the impact of lens materials, design, and manufacturing processes on optical quality. They also explore the importance of considering additional factors such as dysphotopsias, refractive index, and aberrations in the decision-making process to ultimately achieve patient satisfaction. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Mon, 11 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, discuss the impact of lens materials, design, and manufacturing processes on optical quality. They also explore the importance of considering additional factors such as dysphotopsias, refractive index, and aberrations in the decision-making process to ultimately achieve patient satisfaction. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, discuss the impact of lens materials, design, and manufacturing processes on optical quality. They also explore the importance of considering additional factors such as dysphotopsias, refractive index, and aberrations in the decision-making process to ultimately achieve patient satisfaction.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 896 no Fundamentals of Lens Materials https://evolvemeded.com/course/2346-interview-1?utm_source=megaphone&utm_medium=episode_description Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, explore various types of intraocular lens (IOL) materials, including acrylic, silicone, and collamer, and discuss their pros and cons, highlighting differences in manufacturing processes and performance in the eye. The conversation also touches on the importance of proper training in handling different types of lenses and anticipates future developments, particularly in the realm of accommodating IOLs. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Sun, 10 Mar 2024 09:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, explore various types of intraocular lens (IOL) materials, including acrylic, silicone, and collamer, and discuss their pros and cons, highlighting differences in manufacturing processes and performance in the eye. The conversation also touches on the importance of proper training in handling different types of lenses and anticipates future developments, particularly in the realm of accommodating IOLs. This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical. Julie M. Schallhorn, MD, MS, and John A. Vukich, MD, explore various types of intraocular lens (IOL) materials, including acrylic, silicone, and collamer, and discuss their pros and cons, highlighting differences in manufacturing processes and performance in the eye. The conversation also touches on the importance of proper training in handling different types of lenses and anticipates future developments, particularly in the realm of accommodating IOLs.


This activity is supported by independent medical education grants from Alcon, Johnson & Johnson Vision, and STAAR Surgical.

]]> 831 no Small-Aperture Technology https://evolvemeded.com/course/2240-4-OD This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes.  Drs. Douglas K. Devries and Jaclyn Garlich emphasize the importance of managing patient expectations and optimizing ocular surface health, and the impact of these interventions on patients who are myopes, pseudophakic, or have irregular corneas.  This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Thu, 30 Nov 2023 23:44:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes.  Drs. Douglas K. Devries and Jaclyn Garlich emphasize the importance of managing patient expectations and optimizing ocular surface health, and the impact of these interventions on patients who are myopes, pseudophakic, or have irregular corneas.  This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes. 


Drs. Douglas K. Devries and Jaclyn Garlich emphasize the importance of managing patient expectations and optimizing ocular surface health, and the impact of these interventions on patients who are myopes, pseudophakic, or have irregular corneas. 


This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus.

]]> 1068 no Understanding the Impact of Aperture Size on Vision https://evolvemeded.com/course/2240-3-OD This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes.  Drs. Douglas K. Devries and Jaclyn Garlich discuss the impact of aperture size on vision and the importance of putting it into practice now that technologies like presbyopia-correcting eye drops and small-aperture technologies are available. Drs. Devries and Garlich emphasize the need for more research and experience in this area to establish clear guidelines for patient and treatment selection. This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Thu, 30 Nov 2023 23:43:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes.  Drs. Douglas K. Devries and Jaclyn Garlich discuss the impact of aperture size on vision and the importance of putting it into practice now that technologies like presbyopia-correcting eye drops and small-aperture technologies are available. Drs. Devries and Garlich emphasize the need for more research and experience in this area to establish clear guidelines for patient and treatment selection. This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. This episode highlights a consensus statement that was published in a joint CME/CE publication in CRST and Modern Optometry in April 2023, in which 12 optometrists and ophthalmologists convened to discuss and vote on the importance of the optical correlation between pupil size and depth of focus, range of vision, and other visual outcomes. 


Drs. Douglas K. Devries and Jaclyn Garlich discuss the impact of aperture size on vision and the importance of putting it into practice now that technologies like presbyopia-correcting eye drops and small-aperture technologies are available. Drs. Devries and Garlich emphasize the need for more research and experience in this area to establish clear guidelines for patient and treatment selection.


This activity is supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus.

]]> 999 no Best Practices on Communicating With Patients About Small-Aperture Technologies https://evolvemeded.com/course/2240-2-MD Drs. Elizabeth Yeu and William Wiley discuss the importance of understanding presbyopic patients’ needs and expectations as well as considering factors that can impact visual outcomes and patient satisfaction when using pharmacological or small-aperture optics interventions. Drs. Yeu and Wiley highlight the significance of a comprehensive evaluation to guide the decision-making process. Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Thu, 16 Nov 2023 15:42:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Elizabeth Yeu and William Wiley discuss the importance of understanding presbyopic patients’ needs and expectations as well as considering factors that can impact visual outcomes and patient satisfaction when using pharmacological or small-aperture optics interventions. Drs. Yeu and Wiley highlight the significance of a comprehensive evaluation to guide the decision-making process. Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Drs. Elizabeth Yeu and William Wiley discuss the importance of understanding presbyopic patients’ needs and expectations as well as considering factors that can impact visual outcomes and patient satisfaction when using pharmacological or small-aperture optics interventions. Drs. Yeu and Wiley highlight the significance of a comprehensive evaluation to guide the decision-making process.


Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus.

]]> 1040 no Fundamentals of Small-Aperture Optics for Presbyopic Patients https://evolvemeded.com/course/2240-1-MD Drs. Elizabeth Yeu and William Wiley explore the fundamentals of small-aperture optics for presbyopia patients, focusing on the impact of pupil size, aperture size, refractive error, and residual accommodation on surgery and visual outcomes. Drs. Yeu and Wiley emphasize the importance of considering these factors during refractive evaluations and pharmacological and small-aperture optics interventions. This dialogue builds upon a conversation involving 12 optometrists and ophthalmologists previously published in a collaborative CE/CME supplement to CRST and Modern Optometry in April 2023. Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Thu, 16 Nov 2023 15:40:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Elizabeth Yeu and William Wiley explore the fundamentals of small-aperture optics for presbyopia patients, focusing on the impact of pupil size, aperture size, refractive error, and residual accommodation on surgery and visual outcomes. Drs. Yeu and Wiley emphasize the importance of considering these factors during refractive evaluations and pharmacological and small-aperture optics interventions. This dialogue builds upon a conversation involving 12 optometrists and ophthalmologists previously published in a collaborative CE/CME supplement to CRST and Modern Optometry in April 2023. Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus. Drs. Elizabeth Yeu and William Wiley explore the fundamentals of small-aperture optics for presbyopia patients, focusing on the impact of pupil size, aperture size, refractive error, and residual accommodation on surgery and visual outcomes. Drs. Yeu and Wiley emphasize the importance of considering these factors during refractive evaluations and pharmacological and small-aperture optics interventions. This dialogue builds upon a conversation involving 12 optometrists and ophthalmologists previously published in a collaborative CE/CME supplement to CRST and Modern Optometry in April 2023.

Supported by unrestricted educational grants from AbbVie, AcuFocus, Orasis Pharmaceuticals, and Visus.

]]> 1056 no Treating Meibomian Gland Dysfunction https://evolvemeded.com/course/2246-interview-4 Douglas K. Devries, OD, and Walter O. Whitley, OD, MBA, FAAO, discuss the signs and risk factors of meibomian gland dysfunction (MGD) and the methods that can be used to assess the structure and function of the glands. You will learn about the importance of daily lid hygiene and what treatment options are currently available for patients with MGD. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Tue, 28 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Douglas K. Devries, OD, and Walter O. Whitley, OD, MBA, FAAO, discuss the signs and risk factors of meibomian gland dysfunction (MGD) and the methods that can be used to assess the structure and function of the glands. You will learn about the importance of daily lid hygiene and what treatment options are currently available for patients with MGD. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Douglas K. Devries, OD, and Walter O. Whitley, OD, MBA, FAAO, discuss the signs and risk factors of meibomian gland dysfunction (MGD) and the methods that can be used to assess the structure and function of the glands. You will learn about the importance of daily lid hygiene and what treatment options are currently available for patients with MGD.


Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.

]]> 1023 no Assessing Dry Eye Patients https://evolvemeded.com/course/2246-interview-3 Douglas K. Devries, OD, and Leslie O’Dell, OD, FAAO, discuss the incidence of dry eye disease and its impact on patients’ quality of life, especially when considering patients for cataract surgery. Throughout this episode you will also learn the criteria and point-of-care tests currently used to differentiate and diagnose different ocular surface disease categories. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Mon, 27 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Douglas K. Devries, OD, and Leslie O’Dell, OD, FAAO, discuss the incidence of dry eye disease and its impact on patients’ quality of life, especially when considering patients for cataract surgery. Throughout this episode you will also learn the criteria and point-of-care tests currently used to differentiate and diagnose different ocular surface disease categories. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Douglas K. Devries, OD, and Leslie O’Dell, OD, FAAO, discuss the incidence of dry eye disease and its impact on patients’ quality of life, especially when considering patients for cataract surgery. Throughout this episode you will also learn the criteria and point-of-care tests currently used to differentiate and diagnose different ocular surface disease categories.


Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.

]]> 1052 no Examining Lids: A Focus on Demodex Blepharitis and Blepharoptosis https://evolvemeded.com/course/2246-interview-2 Marc R. Bloomenstein, OD, FAAO and Selina R. McGee, OD, FAAO, describe how to evaluate the lids and diagnose Demodex blepharitis and blepharoptosis. You will learn the risk factors for these diseases and how to manage them with current treatment options as well as how to effectively communicate with patients. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Fri, 24 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Marc R. Bloomenstein, OD, FAAO and Selina R. McGee, OD, FAAO, describe how to evaluate the lids and diagnose Demodex blepharitis and blepharoptosis. You will learn the risk factors for these diseases and how to manage them with current treatment options as well as how to effectively communicate with patients. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Marc R. Bloomenstein, OD, FAAO and Selina R. McGee, OD, FAAO, describe how to evaluate the lids and diagnose Demodex blepharitis and blepharoptosis. You will learn the risk factors for these diseases and how to manage them with current treatment options as well as how to effectively communicate with patients.


Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.

]]> 1052 no Emergent Pharmaceutical Treatments for Dry Eye Diseases https://evolvemeded.com/course/2246-interview-1 In this interview, Marc R. Bloomenstein, OD, FAAO, and Mile Brujic, OD, FAAO, describe first-line treatments for patients with dry eye as well as strategies to address their inflammation and tips on educating these patients. You will learn how pharmaceutical management differs from mechanical management and the potential of new and emerging pharmaceutical treatments. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. Thu, 23 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this interview, Marc R. Bloomenstein, OD, FAAO, and Mile Brujic, OD, FAAO, describe first-line treatments for patients with dry eye as well as strategies to address their inflammation and tips on educating these patients. You will learn how pharmaceutical management differs from mechanical management and the potential of new and emerging pharmaceutical treatments. Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical. In this interview, Marc R. Bloomenstein, OD, FAAO, and Mile Brujic, OD, FAAO, describe first-line treatments for patients with dry eye as well as strategies to address their inflammation and tips on educating these patients. You will learn how pharmaceutical management differs from mechanical management and the potential of new and emerging pharmaceutical treatments.


Supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.

]]> 985 no Modern Interventional Treatments for Meibomian Gland Dysfunction In this episode, Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss some findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Moreover, Drs. Devries and Kataria review various palliative and prescription MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments. The faculty also discuss the importance of patient education when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Wed, 22 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss some findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Moreover, Drs. Devries and Kataria review various palliative and prescription MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments. The faculty also discuss the importance of patient education when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. In this episode, Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss some findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Moreover, Drs. Devries and Kataria review various palliative and prescription MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments. The faculty also discuss the importance of patient education when incorporating interventional MGD treatments into a standard clinical practice.


This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.

]]> 960 no The Prevalence and Diagnosis of Meibomian Gland Dysfunction https://evolvemeded.com/course/2205-interview-1-OD Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD among patients with dry eye and ocular surface disease, as well as postoperative cataract patients. Throughout this interview, you will learn how to: examine the eyelid; assess the meibomian gland structure and function; and utilize meibography in your practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Tue, 21 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD among patients with dry eye and ocular surface disease, as well as postoperative cataract patients. Throughout this interview, you will learn how to: examine the eyelid; assess the meibomian gland structure and function; and utilize meibography in your practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD among patients with dry eye and ocular surface disease, as well as postoperative cataract patients. Throughout this interview, you will learn how to: examine the eyelid; assess the meibomian gland structure and function; and utilize meibography in your practice.


This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.

]]> 955 no Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2 In this episode, Drs. Ayres and Gupta discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Faculty review various palliative and prescription-based MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments and how patient education is important when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Wed, 15 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Drs. Ayres and Gupta discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Faculty review various palliative and prescription-based MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments and how patient education is important when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. In this episode, Drs. Ayres and Gupta discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Faculty review various palliative and prescription-based MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments and how patient education is important when incorporating interventional MGD treatments into a standard clinical practice.


This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.

]]> 1256 no Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 1 https://evolvemeded.com/course/2205-interview-1-MD Brandon D. Ayres, MD, and Preeya K. Gupta, MD, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD in dry eye patients, ocular surface disease patients, and cataract surgery patients. In this episode, you will learn how to examine meibomian gland structure and function and how to use meibography in your practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Tue, 14 Mar 2023 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Brandon D. Ayres, MD, and Preeya K. Gupta, MD, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD in dry eye patients, ocular surface disease patients, and cataract surgery patients. In this episode, you will learn how to examine meibomian gland structure and function and how to use meibography in your practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences. Brandon D. Ayres, MD, and Preeya K. Gupta, MD, discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the prevalence of MGD in dry eye patients, ocular surface disease patients, and cataract surgery patients. In this episode, you will learn how to examine meibomian gland structure and function and how to use meibography in your practice.


This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.

]]> 1141 no Integrating Presbyopia Drops Into Optometric Practice https://evolvemeded.com/course/2210_Presby_Interview_4 Drs. Justin Schweitzer and Jade Coats discuss integrating presbyopia-correction options, specifically, presbyopia eye drops, into the optometric practice. You will learn about educating patients, incorporating strategies to drive patients to your practice, and collaborating with other optometrists and ophthalmologists in your area. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Tue, 08 Nov 2022 10:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Justin Schweitzer and Jade Coats discuss integrating presbyopia-correction options, specifically, presbyopia eye drops, into the optometric practice. You will learn about educating patients, incorporating strategies to drive patients to your practice, and collaborating with other optometrists and ophthalmologists in your area. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Drs. Justin Schweitzer and Jade Coats discuss integrating presbyopia-correction options, specifically, presbyopia eye drops, into the optometric practice. You will learn about educating patients, incorporating strategies to drive patients to your practice, and collaborating with other optometrists and ophthalmologists in your area.


Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.

]]> 907 no The Future of Presbyopia With Drops https://evolvemeded.com/course/2210_Presby_Interview_3 In this interview, Drs. Justin Schweitzer and Jade Coats discuss presbyopia-correction options, including pharmaceutical presbyopia drops. You will learn about the impact of presbyopia on quality of life, the drawbacks of conventional presbyopia treatments, and the best candidates for presbyopia eye drops. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Mon, 07 Nov 2022 10:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this interview, Drs. Justin Schweitzer and Jade Coats discuss presbyopia-correction options, including pharmaceutical presbyopia drops. You will learn about the impact of presbyopia on quality of life, the drawbacks of conventional presbyopia treatments, and the best candidates for presbyopia eye drops. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. In this interview, Drs. Justin Schweitzer and Jade Coats discuss presbyopia-correction options, including pharmaceutical presbyopia drops. You will learn about the impact of presbyopia on quality of life, the drawbacks of conventional presbyopia treatments, and the best candidates for presbyopia eye drops.


Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.

]]> 892 no IOL Selection in Presbyopes With Comorbid Conditions (Part 2) https://evolvemeded.com/course/2210_Presby_Interview_2 Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have borderline keratoconus, mild to moderate glaucoma, and epiretinal membrane. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Fri, 04 Nov 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have borderline keratoconus, mild to moderate glaucoma, and epiretinal membrane. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have borderline keratoconus, mild to moderate glaucoma, and epiretinal membrane.


Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.

]]> 958 no IOL Selection in Presbyopes With Comorbid Conditions (Part 1) https://evolvemeded.com/course/2210_Presby_Interview_1 Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have myopia, hyperopia, and mild and severe dry eye including setting expectations pre- and postoperatively. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Thu, 03 Nov 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have myopia, hyperopia, and mild and severe dry eye including setting expectations pre- and postoperatively. Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision. Drs. Marc Bloomenstein and Lindsey Bull discuss IOL selection in patients with comorbid conditions. By the end of this interview, you will learn how to communicate about presbyopia and IOL options with patients who have myopia, hyperopia, and mild and severe dry eye including setting expectations pre- and postoperatively.


Supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.

]]> 822 no Managing Presbyopic Cataract Patients With Comorbid Conditions https://evolvemeded.com/course/2208-interview-2 Drs. Josh Johnston and Jacob Lang discuss IOL options for patients with comorbid conditions. By the end of this episode, you will understand which IOLs work best for patients with ocular surface disease, glaucoma, and retinal disease. Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus. Fri, 16 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Josh Johnston and Jacob Lang discuss IOL options for patients with comorbid conditions. By the end of this episode, you will understand which IOLs work best for patients with ocular surface disease, glaucoma, and retinal disease. Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus. Drs. Josh Johnston and Jacob Lang discuss IOL options for patients with comorbid conditions. By the end of this episode, you will understand which IOLs work best for patients with ocular surface disease, glaucoma, and retinal disease.


Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus.

]]> 1180 no Communicating With Today’s Cataract Patients About Their Presbyopia-Correcting IOL Options https://evolvemeded.com/course/2208-interview-1 Drs. Josh Johnston and Jacob Lang discuss how to properly communicate with patients scheduled for cataract surgery about their IOL options for correcting presbyopia. After listening to this interview, you will understand how to better communicate with both cataract patients and clear lens exchange patients and how to effectively counsel them on their options and manage expectations. Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus. Thu, 15 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Josh Johnston and Jacob Lang discuss how to properly communicate with patients scheduled for cataract surgery about their IOL options for correcting presbyopia. After listening to this interview, you will understand how to better communicate with both cataract patients and clear lens exchange patients and how to effectively counsel them on their options and manage expectations. Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus. Drs. Josh Johnston and Jacob Lang discuss how to properly communicate with patients scheduled for cataract surgery about their IOL options for correcting presbyopia. After listening to this interview, you will understand how to better communicate with both cataract patients and clear lens exchange patients and how to effectively counsel them on their options and manage expectations.


Supported by unrestricted educational grants from Johnson & Johnson Vision and AcuFocus.

]]> 1112 no Managing Different MIGS Patients https://evolvemeded.com/course/2162-interview-3 In this interview, Drs. May, Autry, and Schweitzer discuss managing different MIGS patients. By the end of this episode, you will learn the unique characteristics of different types of MIGS patients and how to effectively communicate with them. Supported by an unrestricted educational grant from Sight Sciences. Mon, 12 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this interview, Drs. May, Autry, and Schweitzer discuss managing different MIGS patients. By the end of this episode, you will learn the unique characteristics of different types of MIGS patients and how to effectively communicate with them. Supported by an unrestricted educational grant from Sight Sciences. In this interview, Drs. May, Autry, and Schweitzer discuss managing different MIGS patients. By the end of this episode, you will learn the unique characteristics of different types of MIGS patients and how to effectively communicate with them.


Supported by an unrestricted educational grant from Sight Sciences.

]]> 1016 no Early Intervention With MIGS https://evolvemeded.com/course/2162-interview-2 In this interview, Drs. May, Autry, and Schweitzer discuss early intervention with MIGS. By the end of this episode, you will learn how MIGS differs from traditional glaucoma surgery. You will also learn the advantages of MIGS, why early intervention is important, and how to identify potential MIGS patients. Supported by an unrestricted educational grant from Sight Sciences. Fri, 09 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this interview, Drs. May, Autry, and Schweitzer discuss early intervention with MIGS. By the end of this episode, you will learn how MIGS differs from traditional glaucoma surgery. You will also learn the advantages of MIGS, why early intervention is important, and how to identify potential MIGS patients. Supported by an unrestricted educational grant from Sight Sciences. In this interview, Drs. May, Autry, and Schweitzer discuss early intervention with MIGS. By the end of this episode, you will learn how MIGS differs from traditional glaucoma surgery. You will also learn the advantages of MIGS, why early intervention is important, and how to identify potential MIGS patients.


Supported by an unrestricted educational grant from Sight Sciences.

]]> 1020 no The Burden of Glaucoma: How Noncompliance Impacts Patients and Doctors https://evolvemeded.com/course/2162-interview-1 In this interview, Kristopher A. May, OD, FAAO, Jill C. Autry OD, RPh, and Justin Schweitzer, OD, FAAO, discuss the impact of noncompliance on doctors and patients. By the end of this episode, you will understand the importance of patient education and how noncompliance can be overcome through alternative treatment. Supported by an unrestricted educational grant from Sight Sciences. Thu, 08 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this interview, Kristopher A. May, OD, FAAO, Jill C. Autry OD, RPh, and Justin Schweitzer, OD, FAAO, discuss the impact of noncompliance on doctors and patients. By the end of this episode, you will understand the importance of patient education and how noncompliance can be overcome through alternative treatment. Supported by an unrestricted educational grant from Sight Sciences. In this interview, Kristopher A. May, OD, FAAO, Jill C. Autry OD, RPh, and Justin Schweitzer, OD, FAAO, discuss the impact of noncompliance on doctors and patients. By the end of this episode, you will understand the importance of patient education and how noncompliance can be overcome through alternative treatment.


Supported by an unrestricted educational grant from Sight Sciences.

]]> 961 no Integrating Presbyopia Drops into Your Practice https://evolvemeded.com/course/2212_presby_course4 Dr. John Berdahl and Dr. John Hovanesian discuss the impact presbyopia eye drops have on public health and the presbyopic patient. By the end of this episode, you will learn about patient selection, the associated risks, and patient management. You will also learn about the roles optometry and ophthalmology play in presbyopia management. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Wed, 07 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Dr. John Berdahl and Dr. John Hovanesian discuss the impact presbyopia eye drops have on public health and the presbyopic patient. By the end of this episode, you will learn about patient selection, the associated risks, and patient management. You will also learn about the roles optometry and ophthalmology play in presbyopia management. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Dr. John Berdahl and Dr. John Hovanesian discuss the impact presbyopia eye drops have on public health and the presbyopic patient. By the end of this episode, you will learn about patient selection, the associated risks, and patient management. You will also learn about the roles optometry and ophthalmology play in presbyopia management.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics.

]]> 975 no The Future of Presbyopia with Drops https://evolvemeded.com/course/2212_presby_course3 In this episode, John P. Berdahl, MD and John A. Hovanesian, MD discuss presbyopia eye drops as another treatment option. You will learn about the psychological and physical impacts of presbyopia and the limitations of current treatment options. You will also learn about patient selection and management with presbyopia drops. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Tue, 06 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, John P. Berdahl, MD and John A. Hovanesian, MD discuss presbyopia eye drops as another treatment option. You will learn about the psychological and physical impacts of presbyopia and the limitations of current treatment options. You will also learn about patient selection and management with presbyopia drops. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. In this episode, John P. Berdahl, MD and John A. Hovanesian, MD discuss presbyopia eye drops as another treatment option. You will learn about the psychological and physical impacts of presbyopia and the limitations of current treatment options. You will also learn about patient selection and management with presbyopia drops.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics.

]]> 914 no Keys to Effective Presbyopia Patient Conversations https://evolvemeded.com/course/2212_presby_course2 In this episode, Dr. Marjan Farid and Dr. Julie Schallhorn discuss the keys to effective presbyopia patient conversation. You will learn how to assess patients’ needs through lifestyle questionnaires and the importance of proper management of ocular surface disease. You will also learn how age, hobbies, and preoperative refractive errors affect patient expectations. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Fri, 02 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Dr. Marjan Farid and Dr. Julie Schallhorn discuss the keys to effective presbyopia patient conversation. You will learn how to assess patients’ needs through lifestyle questionnaires and the importance of proper management of ocular surface disease. You will also learn how age, hobbies, and preoperative refractive errors affect patient expectations. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. In this episode, Dr. Marjan Farid and Dr. Julie Schallhorn discuss the keys to effective presbyopia patient conversation. You will learn how to assess patients’ needs through lifestyle questionnaires and the importance of proper management of ocular surface disease. You will also learn how age, hobbies, and preoperative refractive errors affect patient expectations.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics.

]]> 759 no The Newest Presbyopia Correcting IOLs https://evolvemeded.com/course/2212_presby_course1 Marjan Farid, MD and Julie Schallhorn, MD, MS discuss the newest generation of intraocular lenses available for cataract patients. By the end of this episode, you will learn about the newest generation of IOLs, patient selection and management of patient expectations. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Thu, 01 Sep 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Marjan Farid, MD and Julie Schallhorn, MD, MS discuss the newest generation of intraocular lenses available for cataract patients. By the end of this episode, you will learn about the newest generation of IOLs, patient selection and management of patient expectations. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics. Marjan Farid, MD and Julie Schallhorn, MD, MS discuss the newest generation of intraocular lenses available for cataract patients. By the end of this episode, you will learn about the newest generation of IOLs, patient selection and management of patient expectations.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus Therapeutics.

]]> 900 no How to Bring Refractive Lens Exchange Into Your Practice https://evolvemeded.com/course/2209-RLE-course4 Drs. Eric Donnenfeld and Cathleen McCabe discuss implementing refractive lens exchange in your practice. You will understand how to identify refractive lens exchange candidates and alternative treatments for patients who may not be candidates. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Wed, 31 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld and Cathleen McCabe discuss implementing refractive lens exchange in your practice. You will understand how to identify refractive lens exchange candidates and alternative treatments for patients who may not be candidates. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Drs. Eric Donnenfeld and Cathleen McCabe discuss implementing refractive lens exchange in your practice. You will understand how to identify refractive lens exchange candidates and alternative treatments for patients who may not be candidates.


Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision.

]]> 710 no Identifying Refractive Lens Exchange Candidates https://evolvemeded.com/course/2209-RLE-course3 In this episode, Drs. Eric Donnenfeld and Cathleen McCabe discuss refractive lens exchange for today’s patients with presbyopia. Upon conclusion of this eipsode, you will understand who makes the best candidate for a refractive lens exchange and when it should be performed. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Tue, 30 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Drs. Eric Donnenfeld and Cathleen McCabe discuss refractive lens exchange for today’s patients with presbyopia. Upon conclusion of this eipsode, you will understand who makes the best candidate for a refractive lens exchange and when it should be performed. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. In this episode, Drs. Eric Donnenfeld and Cathleen McCabe discuss refractive lens exchange for today’s patients with presbyopia. Upon conclusion of this eipsode, you will understand who makes the best candidate for a refractive lens exchange and when it should be performed.


Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision.

]]> 1340 no The Modern Refractive Lens Exchange Practice https://evolvemeded.com/course/2209-RLE-course2 Drs. Kendall E. Donaldson and John A. Vukich discuss the modern refractive lens exchange practice. By the end of this class, you will learn about the new techniques and technology available and how to manage patient expectations. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Mon, 29 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Kendall E. Donaldson and John A. Vukich discuss the modern refractive lens exchange practice. By the end of this class, you will learn about the new techniques and technology available and how to manage patient expectations. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Drs. Kendall E. Donaldson and John A. Vukich discuss the modern refractive lens exchange practice. By the end of this class, you will learn about the new techniques and technology available and how to manage patient expectations.


Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision.

]]> 1201 no Refractive Lens Exchange for Today’s Presbyopes https://evolvemeded.com/course/2209-RLE-course1 In this episode, Drs. Kendall E. Donaldson and John A. Vukich discuss the latest in presbyopia-correcting IOL technologies and how they create new groups of satisfied patients. By the end of this class, you will learn the key characteristics of patients who are ideal candidates for refractive lens exchange. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. Fri, 26 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Drs. Kendall E. Donaldson and John A. Vukich discuss the latest in presbyopia-correcting IOL technologies and how they create new groups of satisfied patients. By the end of this class, you will learn the key characteristics of patients who are ideal candidates for refractive lens exchange. Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision. In this episode, Drs. Kendall E. Donaldson and John A. Vukich discuss the latest in presbyopia-correcting IOL technologies and how they create new groups of satisfied patients. By the end of this class, you will learn the key characteristics of patients who are ideal candidates for refractive lens exchange.


Supported by independent unrestricted educational grants from AcuFocus and Johnson & Johnson Vision.

]]> 1533 no Premium IOL Selection for Hyperopic and Complex Cataract Patients https://evolvemeded.com/course/2157-interviews-3-4 In this episode, Drs. Karolinne Rocha and George Waring discuss premium IOL selection. For hyperopic patients, you will learn about hybrid multifocal/extended depth of focus (EDOF) IOLs and how to select the right IOL using calculators to provide the best outcomes. For complex cataract patients, you will learn how to manage patient expectations, identify and treat ocular pathology including dry eye masqueraders prior to surgery, and select the appropriate IOL for each unique case. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. Thu, 25 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Drs. Karolinne Rocha and George Waring discuss premium IOL selection. For hyperopic patients, you will learn about hybrid multifocal/extended depth of focus (EDOF) IOLs and how to select the right IOL using calculators to provide the best outcomes. For complex cataract patients, you will learn how to manage patient expectations, identify and treat ocular pathology including dry eye masqueraders prior to surgery, and select the appropriate IOL for each unique case. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. In this episode, Drs. Karolinne Rocha and George Waring discuss premium IOL selection. For hyperopic patients, you will learn about hybrid multifocal/extended depth of focus (EDOF) IOLs and how to select the right IOL using calculators to provide the best outcomes. For complex cataract patients, you will learn how to manage patient expectations, identify and treat ocular pathology including dry eye masqueraders prior to surgery, and select the appropriate IOL for each unique case.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus.

]]> 1696 no Incorporating Pharmaceutical Presbyopia Treatments Into Your Practice https://evolvemeded.com/course/2157-interview-2 Drs. Eric Donnenfeld and Vance Thompson discuss incorporating presbyopia therapies into practice for older patients. You will learn the role of surgical and pharmaceutical management with older patients. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. Wed, 24 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld and Vance Thompson discuss incorporating presbyopia therapies into practice for older patients. You will learn the role of surgical and pharmaceutical management with older patients. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. Drs. Eric Donnenfeld and Vance Thompson discuss incorporating presbyopia therapies into practice for older patients. You will learn the role of surgical and pharmaceutical management with older patients.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus.

]]> 680 no Key Features of Pharmaceutical Presbyopia Treatments https://evolvemeded.com/course/2157-interview-1 Drs. Eric Donnenfeld and Vance Thompson discuss expanding the presbyopia practice. You will learn about the latest technologies that can help grow your presbyopia practice. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. Tue, 23 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld and Vance Thompson discuss expanding the presbyopia practice. You will learn about the latest technologies that can help grow your presbyopia practice. Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus. Drs. Eric Donnenfeld and Vance Thompson discuss expanding the presbyopia practice. You will learn about the latest technologies that can help grow your presbyopia practice.


Supported by unrestricted educational grants from AcuFocus, Johnson & Johnson Vision, and Visus.

]]> 827 no Accessing That Leathery Posterior Plate - The Flip https://evolvemeded.com/course/2158-case-6 In this episode, Steven H. Dewey, MD discusses dense, leathery cataracts and how to deal with them. You will learn about the advantages of the flip, the dense cataract considerations, and the proper flip technique. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Mon, 22 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Steven H. Dewey, MD discusses dense, leathery cataracts and how to deal with them. You will learn about the advantages of the flip, the dense cataract considerations, and the proper flip technique. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. In this episode, Steven H. Dewey, MD discusses dense, leathery cataracts and how to deal with them. You will learn about the advantages of the flip, the dense cataract considerations, and the proper flip technique.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 1091 no Any Density Nucleus Horizontal Chop https://evolvemeded.com/course/2158-case-5 Steven H. Dewey, MD, discusses density nucleus horizontal chop in cataract surgery. You will learn about the fundamentals for dense nuclei, and how to approach, engage, and manipulate horizontal chop. You will also learn how to troubleshoot a failed chop in dense cataracts and emulsification. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Fri, 19 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Steven H. Dewey, MD, discusses density nucleus horizontal chop in cataract surgery. You will learn about the fundamentals for dense nuclei, and how to approach, engage, and manipulate horizontal chop. You will also learn how to troubleshoot a failed chop in dense cataracts and emulsification. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Steven H. Dewey, MD, discusses density nucleus horizontal chop in cataract surgery. You will learn about the fundamentals for dense nuclei, and how to approach, engage, and manipulate horizontal chop. You will also learn how to troubleshoot a failed chop in dense cataracts and emulsification.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 1033 no Trenching to Transition to Horizontal Chop https://evolvemeded.com/course/2158-case-4 Steven H. Dewey, MD, discusses trenching to transition to horizontal chop in cataract surgery. By the end of this episode, you will learn about the advantages and disadvantages of this procedure, the instruments used, and the step-by-step procedure guide. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Thu, 18 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Steven H. Dewey, MD, discusses trenching to transition to horizontal chop in cataract surgery. By the end of this episode, you will learn about the advantages and disadvantages of this procedure, the instruments used, and the step-by-step procedure guide. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Steven H. Dewey, MD, discusses trenching to transition to horizontal chop in cataract surgery. By the end of this episode, you will learn about the advantages and disadvantages of this procedure, the instruments used, and the step-by-step procedure guide.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 703 no Dense Cataract with Iridodialysis Repair https://evolvemeded.com/course/2158-case-3 In this episode, Cathleen M. McCabe, MD discusses the complex case of dense cataract with iridodialysis repair. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Wed, 17 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Cathleen M. McCabe, MD discusses the complex case of dense cataract with iridodialysis repair. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. In this episode, Cathleen M. McCabe, MD discusses the complex case of dense cataract with iridodialysis repair.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 1152 no Managing a Traumatic Subluxed Cataract https://evolvemeded.com/course/2158-case-2 In this episode, Cathleen M. McCabe, MD discusses the complex case of traumatic subluxed cataract. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Tue, 16 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Cathleen M. McCabe, MD discusses the complex case of traumatic subluxed cataract. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. In this episode, Cathleen M. McCabe, MD discusses the complex case of traumatic subluxed cataract.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 1132 no The Challenge of Weak Zonules https://evolvemeded.com/course/2158-case-1 In this episode, Dr. David F. Chang discusses the challenge of weak zonules and pearls for addressing this type of phacoemulsification complex case. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. Mon, 15 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, Dr. David F. Chang discusses the challenge of weak zonules and pearls for addressing this type of phacoemulsification complex case. Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision. In this episode, Dr. David F. Chang discusses the challenge of weak zonules and pearls for addressing this type of phacoemulsification complex case.


Supported by independent education grants from Johnson & Johnson Vision and Alcon Vision.

]]> 674 no Keratoconus and Blepharoptosis https://evolvemeded.com/course/2153-4-on-demand This new optometric Master Class education program focuses on keratoconus and blepharoptosis treatment and patient outcomes. Presented by Dr. Douglas Devries and Dr. Mile Brujic. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. Fri, 12 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group This new optometric Master Class education program focuses on keratoconus and blepharoptosis treatment and patient outcomes. Presented by Dr. Douglas Devries and Dr. Mile Brujic. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. This new optometric Master Class education program focuses on keratoconus and blepharoptosis treatment and patient outcomes. Presented by Dr. Douglas Devries and Dr. Mile Brujic.


Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea.

]]> 1285 no Treating Meibomian Gland Dysfunction https://evolvemeded.com/course/2153-3-on-demand In this episode, subject matter experts Drs. Douglas Devries and Walter Whitley describe how to utilize new and emerging therapies for treating meibomian gland dysfunction. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. Thu, 11 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group In this episode, subject matter experts Drs. Douglas Devries and Walter Whitley describe how to utilize new and emerging therapies for treating meibomian gland dysfunction. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. In this episode, subject matter experts Drs. Douglas Devries and Walter Whitley describe how to utilize new and emerging therapies for treating meibomian gland dysfunction.


Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea.

]]> 789 no Aqueous Dry Eye Treatment Recommendations https://evolvemeded.com/course/2153-2-on-demand Drs. Marc Bloomenstein and Josh Johnston discuss best practices for the treatment of aqueous dry eye. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. Wed, 10 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Marc Bloomenstein and Josh Johnston discuss best practices for the treatment of aqueous dry eye. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. Drs. Marc Bloomenstein and Josh Johnston discuss best practices for the treatment of aqueous dry eye.


Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea.

]]> 1034 no The Prevalence and Impact of Dry Eye Disease https://evolvemeded.com/course/2153-1-on-demand This interview with Drs. Marc Bloomenstein and Cecelia Koetting highlights the prevalence and impact of dry eye disease. The impact of this disease of these groups will be discussed: Ocular Surface Disease patients, Cataract and refractive surgery patients, Contact lens dropout patients. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. Tue, 09 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group This interview with Drs. Marc Bloomenstein and Cecelia Koetting highlights the prevalence and impact of dry eye disease. The impact of this disease of these groups will be discussed: Ocular Surface Disease patients, Cataract and refractive surgery patients, Contact lens dropout patients. Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea. This interview with Drs. Marc Bloomenstein and Cecelia Koetting highlights the prevalence and impact of dry eye disease. The impact of this disease of these groups will be discussed: Ocular Surface Disease patients, Cataract and refractive surgery patients, Contact lens dropout patients.


Supported by unrestricted educational grants from Alcon, Avellino, Bausch + Lomb, Johnson & Johnson Vision, RVL, Santen, Sight Sciences, Tarsus, TearLab, and Thea.

]]> 953 no ODs: Keratoconus Testing Consensus Roundtable: Part 3 https://evolvemeded.com/course/2119%20OD_Video_Part_3 Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels. Supported by an unrestricted educational grant from Avellino. Mon, 08 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels. Supported by an unrestricted educational grant from Avellino. Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels.


Supported by an unrestricted educational grant from Avellino.

]]> 1301 no ODs: Keratoconus Testing Consensus Roundtable: Part 2 https://evolvemeded.com/course/2119%20OD_Video_%20Part_2 Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing. Supported by an unrestricted educational grant from Avellino. Fri, 05 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing. Supported by an unrestricted educational grant from Avellino. Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing.


Supported by an unrestricted educational grant from Avellino.

]]> 1731 no ODs: Keratoconus Testing Consensus Roundtable: Part 1 https://evolvemeded.com/course/2119%20OD_Video_%20Part_1 Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients. Supported by an unrestricted educational grant from Avellino. Thu, 04 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients. Supported by an unrestricted educational grant from Avellino. Drs. Barry Eiden, Melissa Barnett, Mile Brujic, Gloria Chiu, John Gelles, and Andy Morgenstern describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients.


Supported by an unrestricted educational grant from Avellino.

]]> 1796 no MDs: Keratoconus Testing Consensus Roundtable: Part 3 https://evolvemeded.com/course/2119%20MD_Video_%20Part_3 Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels. Supported by an unrestricted educational grant from Avellino. Wed, 03 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels. Supported by an unrestricted educational grant from Avellino. Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu discuss the incremental impact of keratoconus on visual outcomes and quality of life as the disease progresses, as well as the impact on corneal refractive surgery practice when a patient develop post-refractive surgery ectasia. They discuss treatment options for keratoconus patients in various disease progression levels.


Supported by an unrestricted educational grant from Avellino.

]]> 1688 no MDs: Keratoconus Testing Consensus Roundtable: Part 2 https://evolvemeded.com/course/2119%20MD_Video_%20Part_2 Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing. Supported by an unrestricted educational grant from Avellino. Tue, 02 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing. Supported by an unrestricted educational grant from Avellino. Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe recommended diagnostic work-up protocols and preemptive testing indications for various groups of corneal refractive surgery candidates to maximize the diagnosis of keratoconus suspects. They discuss the red flags and cornea concerns that would lead one to recommend a genetic test to identify a potential keratoconus suspect, as well as the actionable decisions you make based on the data you receive from genetic testing.


Supported by an unrestricted educational grant from Avellino.

]]> 1672 no MDs: Keratoconus Testing Consensus Roundtable: Part 1 https://evolvemeded.com/course/2119%20MD_Video_%20Part_1 Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients. Supported by an unrestricted educational grant from Avellino. Mon, 01 Aug 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients. Supported by an unrestricted educational grant from Avellino. Drs. Eric Donnenfeld, Ashley Brissette, Terry Kim, Richard Lindstrom, Neda Shamie, Bill Trattler, and Liz Yeu describe keratoconus, risk factors associated with the disease, and key parameters of keratoconus progression. They discuss the incidence and prevalence of keratoconus with various patient groups, as well as the standard diagnostic test criteria that should be used to identify keratoconus patients.


Supported by an unrestricted educational grant from Avellino.

]]> 1485 no Treating Flares vs. Chronic Dry Eye Disease https://evolvemeded.com/course/2042_Video_3 Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss strategies to treat dry eye patients, as compared to patients with dry eye flares. This is Part 3 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Fri, 29 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss strategies to treat dry eye patients, as compared to patients with dry eye flares. This is Part 3 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss strategies to treat dry eye patients, as compared to patients with dry eye flares. This is Part 3 of 3.


Supported by an independent education grant from Kala Pharmaceuticals.

]]> 428 no Diagnosing and Treating Dry Eye Flares https://evolvemeded.com/course/2042_Video_2 Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss the key tests they use to diagnose dry eye flares. They also discuss treatment options for patients with dry eye flares. This is Part 2 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Thu, 28 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss the key tests they use to diagnose dry eye flares. They also discuss treatment options for patients with dry eye flares. This is Part 2 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss the key tests they use to diagnose dry eye flares. They also discuss treatment options for patients with dry eye flares. This is Part 2 of 3.


Supported by an independent education grant from Kala Pharmaceuticals.

]]> 550 no Definition and Impact of Dry Eye Flares https://evolvemeded.com/course/2042_Video_1 Drs. Eric D. Donnenfeld and Preeya K. Gupta define acute exacerbations of dry eye disease as flares and discuss the impact of dry eye flares on a patient’s quality of life as well as surgical outcomes. This is Part 1 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Wed, 27 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Eric D. Donnenfeld and Preeya K. Gupta define acute exacerbations of dry eye disease as flares and discuss the impact of dry eye flares on a patient’s quality of life as well as surgical outcomes. This is Part 1 of 3. Supported by an independent education grant from Kala Pharmaceuticals. Drs. Eric D. Donnenfeld and Preeya K. Gupta define acute exacerbations of dry eye disease as flares and discuss the impact of dry eye flares on a patient’s quality of life as well as surgical outcomes. This is Part 1 of 3.


Supported by an independent education grant from Kala Pharmaceuticals.

]]> 693 no Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs https://evolvemeded.com/course/2037_Video_3 Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances. They discuss how to manage patient expectations for presbyopia correcting IOL patients during the preoperative consultation, and how to determine the visual distance needs of presbyopia patients. They describe how they manage patients with comorbid conditions, like glaucoma, post-corneal refractive surgery, and other corneal abnormalities. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Tue, 26 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances. They discuss how to manage patient expectations for presbyopia correcting IOL patients during the preoperative consultation, and how to determine the visual distance needs of presbyopia patients. They describe how they manage patients with comorbid conditions, like glaucoma, post-corneal refractive surgery, and other corneal abnormalities. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances. They discuss how to manage patient expectations for presbyopia correcting IOL patients during the preoperative consultation, and how to determine the visual distance needs of presbyopia patients. They describe how they manage patients with comorbid conditions, like glaucoma, post-corneal refractive surgery, and other corneal abnormalities.


Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.

]]> 2427 no Next-Generation Presbyopia-Correcting IOLs https://evolvemeded.com/course/2037_Video_2 Drs. Cathy McCabe and Ike Ahmed discuss the types of presbyopia cataract patients that can be addressed with the latest generation of presbyopia-correcting IOLs that may have not been happy with presbyopia correction previous to this. They describe the new enhanced monofocal IOL (Eyhance), extended range of vision IOL (Vivity), and hybrid EDOF/multifocal IOL (Synergy), and how these new IOLs will expand presbyopia practices. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Mon, 25 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Cathy McCabe and Ike Ahmed discuss the types of presbyopia cataract patients that can be addressed with the latest generation of presbyopia-correcting IOLs that may have not been happy with presbyopia correction previous to this. They describe the new enhanced monofocal IOL (Eyhance), extended range of vision IOL (Vivity), and hybrid EDOF/multifocal IOL (Synergy), and how these new IOLs will expand presbyopia practices. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Drs. Cathy McCabe and Ike Ahmed discuss the types of presbyopia cataract patients that can be addressed with the latest generation of presbyopia-correcting IOLs that may have not been happy with presbyopia correction previous to this. They describe the new enhanced monofocal IOL (Eyhance), extended range of vision IOL (Vivity), and hybrid EDOF/multifocal IOL (Synergy), and how these new IOLs will expand presbyopia practices.


Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.

]]> 1720 no Innovations in Pharmacological Treatments for Presbyopic Patients https://evolvemeded.com/course/2037_Video_1 Drs. Marjan Farid and Nicole Fram discuss the key efficacy, safety, and comfort considerations when using these new pharmaceutical presbyopia treatments. They also describe the patients that will be the best candidates for pharmaceutical presbyopia treatments. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Fri, 22 Jul 2022 09:00:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Drs. Marjan Farid and Nicole Fram discuss the key efficacy, safety, and comfort considerations when using these new pharmaceutical presbyopia treatments. They also describe the patients that will be the best candidates for pharmaceutical presbyopia treatments. Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. Drs. Marjan Farid and Nicole Fram discuss the key efficacy, safety, and comfort considerations when using these new pharmaceutical presbyopia treatments. They also describe the patients that will be the best candidates for pharmaceutical presbyopia treatments.


Supported by unrestricted educational grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.

]]> 848 no Welcome to Eyecare Innovations Today Each episode will feature expert ophthalmologists and optometrists with diverse backgrounds sharing the latest technology innovations in eye care. Thu, 21 Jul 2022 17:22:00 -0000 full Evolve Medical Education, LLC and The Fundingsland Group Each episode will feature expert ophthalmologists and optometrists with diverse backgrounds sharing the latest technology innovations in eye care. Each episode will feature expert ophthalmologists and optometrists with diverse backgrounds sharing the latest technology innovations in eye care.

]]> 75 no